Back to top
more

Elevance Health, Inc. (ELV)

(Real Time Quote from BATS)

$417.80 USD

417.80
623,012

-0.06 (-0.01%)

Updated Nov 5, 2024 12:53 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (154 out of 250)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?

by Zacks Equity Research

Sector ETF report for IHF

The Zacks Analyst Blog Highlights Alphabet, Procter & Gamble, Linde, Comcast and Elevance Health

by Zacks Equity Research

Alphabet, Procter & Gamble, Linde, Comcast and Elevance Health are included in this Analyst Blog.

Sheraz Mian headshot

Top Analyst Reports for Alphabet, Procter & Gamble & Linde

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), The Procter & Gamble Company (PG) and Linde plc (LIN).

Company News for Jul 20, 2023

by Zacks Equity Research

Companies In The News Are: MTB, ELV, BKR, NTRS.

Elevance Health (ELV) Beats on Q2 Earnings, Ups '23 Profit View

by Zacks Equity Research

Elevance Health's (ELV) Q2 results benefit from an expanding customer base and solid pharmacy product revenues. Adjusted net income is expected to be more than $32.85 per share for 2023.

Elevance Health (ELV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

The headline numbers for Elevance Health (ELV) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Elevance Health (ELV) Surpasses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Elevance Health (ELV) delivered earnings and revenue surprises of 2.49% and 4.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Will Carelon Growth Aid Elevance Health's (ELV) Q2 Earnings?

by Zacks Equity Research

Elevance Health's (ELV) second-quarter results are likely to reflect rising memberships in Medicare Advantage, Medicaid, Vision and Dental Administration businesses.

Elevance Health (ELV) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Elevance Health (ELV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Zacks Analyst Blog Highlights Linde, Elevance Health, Lam Research, KLA and Johnson Controls

by Zacks Equity Research

Linde, Elevance Health, Lam Research, KLA and Johnson Controls are part of the Zacks top Analyst Blog.

Sheraz Mian headshot

Top Stock Reports for Linde, Elevance Health & Lam Research

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Linde plc (LIN), Elevance Health, Inc. (ELV) and Lam Research Corporation (LRCX).

DocGo Inc. (DCGO) Surges 5.0%: Is This an Indication of Further Gains?

by Zacks Equity Research

DocGo Inc. (DCGO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Sheraz Mian headshot

Top Stock Reports for Meta Platforms, Boeing & IBM

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), The Boeing Company (BA) and International Business Machines Corporation (IBM).

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Mark Vickery headshot

Top Research Reports for Tesla, TotalEnergies & Intuitive Surgical

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc. (TSLA), TotalEnergies SE (TTE) and Intuitive Surgical, Inc. (ISRG).

Why Elevance Health (ELV) is a Top Value Stock for the Long-Term

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?

by Zacks Equity Research

Sector ETF report for IHF

Here's Why You Should Hold Elevance (ELV) in Your Portfolio

by Zacks Equity Research

Improving top line, investments in high-growth businesses, membership hikes and significant new contracts in its government business poise Elevance Health (ELV) well for growth.

Why Is Elevance Health (ELV) Up 0% Since Last Earnings Report?

by Zacks Equity Research

Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Cigna (CI) Q1 Earnings Surpass Estimates, Ups '23 EPS View

by Zacks Equity Research

Cigna's (CI) first-quarter 2023 results indicate a strong contribution to revenues from Evernorth Health Services and Cigna Healthcare businesses. Management currently expects adjusted EPS to be a minimum of $24.70 in 2023.

Acadia Healthcare (ACHC) Q1 Earnings Beat on Higher Patient Volumes

by Zacks Equity Research

Acadia Healthcare's (ACHC) Q1 results reflect higher revenue per patient day, partly offset by an elevated cost level. Management reaffirms its 2023 business guidance.

Teladoc Health (TDOC) Shares Up 5% Since Q1 Earnings Release

by Zacks Equity Research

Teladoc Health's (TDOC) Q1 results reflect solid chronic care product revenues and improving access fees and other revenues.

ELV vs. AMEH: Which Stock Is the Better Value Option?

by Zacks Equity Research

ELV vs. AMEH: Which Stock Is the Better Value Option?

AMN Healthcare (AMN) to Post Q1 Earnings: What's in the Cards?

by Zacks Equity Research

AMN Healthcare's (AMN) first-quarter results are likely to reflect soft demand across its segments.